HealthBeacon Past Earnings Performance
Past criteria checks 0/6
HealthBeacon's earnings have been declining at an average annual rate of -39.3%, while the Medical Equipment industry saw earnings growing at 6.8% annually. Revenues have been declining at an average rate of 11.5% per year.
Key information
-39.3%
Earnings growth rate
4.0%
EPS growth rate
| Medical Equipment Industry Growth | 12.3% |
| Revenue growth rate | -11.5% |
| Return on equity | -129.8% |
| Net Margin | -628.9% |
| Last Earnings Update | 30 Jun 2023 |
Recent past performance updates
Recent updates
Here's Why HealthBeacon (ISE:HBCN) Must Use Its Cash Wisely
Jun 15
We're Keeping An Eye On HealthBeacon's (ISE:HBCN) Cash Burn Rate
Feb 15Here's Why We're Watching HealthBeacon's (ISE:HBCN) Cash Burn Situation
Nov 02HealthBeacon (ISE:HBCN) Is In A Good Position To Deliver On Growth Plans
Jul 20Companies Like HealthBeacon (ISE:HBCN) Are In A Position To Invest In Growth
Apr 05Revenue & Expenses BreakdownBeta
How HealthBeacon makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 23 | 2 | -14 | 11 | 0 |
| 31 Mar 23 | 2 | -14 | 11 | 0 |
| 31 Dec 22 | 2 | -13 | 11 | 0 |
| 30 Sep 22 | 2 | -13 | 9 | 0 |
| 30 Jun 22 | 3 | -12 | 6 | 0 |
| 31 Mar 22 | 2 | -10 | 6 | 0 |
| 31 Dec 21 | 2 | -8 | 6 | 0 |
| 30 Sep 21 | 2 | -6 | 4 | 0 |
| 30 Jun 21 | 1 | -5 | 2 | 0 |
| 31 Mar 21 | 1 | -4 | 3 | 0 |
| 31 Dec 20 | 1 | -3 | 3 | 0 |
| 31 Dec 19 | 2 | -3 | 3 | 0 |
| 31 Dec 18 | 1 | -2 | 2 | 0 |
Quality Earnings: HBCN is currently unprofitable.
Growing Profit Margin: HBCN is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: HBCN is unprofitable, and losses have increased over the past 5 years at a rate of 39.3% per year.
Accelerating Growth: Unable to compare HBCN's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: HBCN is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (4.6%).
Return on Equity
High ROE: HBCN has a negative Return on Equity (-129.77%), as it is currently unprofitable.